In contrast, multiple BRAF-independent mutations, mainly out of the MAPK pathway were detected in single CTCs by targeted PCR/NGS, while the number of these mutations was much lower in tumour biopsies and cfDNA samples. The gene discussed is BRAF; the disease is neoplasm.